Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats Akiyoshi SaitohKazumasa YamaguchiJunzo Kamei Original Investigation 22 February 2007 Pages: 857 - 865
Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats Nicole L. Schramm-SapytaYoung May ChaCynthia M. Kuhn Original Investigation 09 January 2007 Pages: 867 - 877
Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition Jennifer L. SzczytkowskiDonald T. Lysle Original Investigation 09 January 2007 Pages: 879 - 889
Nicotine increases FosB expression within a subset of reward- and memory-related brain regions during both peri- and post-adolescence Ken SoderstromWeixi QinBrian A. McMillen Original Investigation 27 February 2007 Pages: 891 - 897
The effects of a single session of inescapable tailshock on the subsequent locomotor response to brief footshock and cocaine administration in rats Andre Der-AvakianRobert R. RozeskeSteven F. Maier Original Investigation 09 January 2007 Pages: 899 - 907
The effects of a single exposure to uncontrollable stress on the subsequent conditioned place preference responses to oxycodone, cocaine, and ethanol in rats Andre Der-AvakianSondra T. BlandSteven F. Maier Original Investigation 09 January 2007 Pages: 909 - 917
Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers G. DunbarP. H. BoeijingaR. Luthringer Original Investigation 16 January 2007 Pages: 919 - 929
The effects of buprenorphine on fentanyl withdrawal in rats Adrie W. BruijnzeelCatherine MarcinkiewczMark S. Gold Original Investigation 09 January 2007 Pages: 931 - 941
A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers Louise M. PatersonSue J. WilsonMagnus Ivarsson Original Investigation 16 January 2007 Pages: 943 - 950
Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg Tim R. M. LeufkensAnnemiek VermeerenJohannes G. Ramaekers Original Investigation 12 January 2007 Pages: 951 - 959
The supramammillo–septal–hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats Jingyi MaL. Stan Leung Original Investigation 12 January 2007 Pages: 961 - 974
Tiagabine does not attenuate alcohol-induced activation of the human reward system Christoph FehrNina HohmannMathias Schreckenberger Original Investigation 30 January 2007 Pages: 975 - 983
Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice Kelly A. CarriganLinda A. Dykstra Original Investigation 09 January 2007 Pages: 985 - 993
A pharmaco-EEG study on antipsychotic drugs in healthy volunteers Masafumi YoshimuraThomas KoenigThomas Dierks Original Investigation 27 February 2007 Pages: 995 - 1004
Changes in brain 11C–nicotine binding sites in patients with mild Alzheimer’s disease following rivastigmine treatment as assessed by PET Ahmadul KadirTaher Darreh-ShoriAgneta Nordberg Original Investigation 20 February 2007 Pages: 1005 - 1014
Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study Diego NovickJosep Maria HaroDieter Naber Original Investigation 20 February 2007 Pages: 1015 - 1022
Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up Marius K. NickelThomas H. LoewFrancisco Pedrosa Gil Original Investigation 23 February 2007 Pages: 1023 - 1026
Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial Dieter NaberAndrew GreenspanAndreas Schreiner Letter to the Editors 27 February 2007 Pages: 1027 - 1029
